1. 2016 Children's Tumor Foundation conference on neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis. Issue 5 (21st April 2018) Authors: Fisher, Michael J.; Belzberg, Allan J.; de Blank, Peter; De Raedt, Thomas; Elefteriou, Florent; Ferner, Rosalie E.; Giovannini, Marco; Harris, Gordon J.; Kalamarides, Michel; Karajannis, Matthias A.; Kim, AeRang; Lázaro, Conxi; Le, Lu Q.; Li, Wei; Listernick, Robert; Martin, Staci; Morrison, Hele... Journal: American journal of medical genetics Issue: Volume 176:Issue 5(2018) Page Start: 1258 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. BRAF inhibitor resistance of melanoma cells triggers increased susceptibility to natural killer cell-mediated lysis. Issue 2 (9th September 2020) Authors: Frazao, Alexandra; Rethacker, Louise; Jeudy, Géraldine; Colombo, Marina; Pasmant, Eric; Avril, Marie-Françoise; Toubert, Antoine; Moins-Teisserenc, Helene; Roelens, Marie; Dalac, Sophie; Maubec, Eve; Caignard, Anne Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. BRAF inhibitor resistance of melanoma cells triggers increased susceptibility to natural killer cell-mediated lysis. Issue 2 (9th September 2020) Authors: Frazao, Alexandra; Rethacker, Louise; Jeudy, Géraldine; Colombo, Marina; Pasmant, Eric; Avril, Marie-Françoise; Toubert, Antoine; Moins-Teisserenc, Helene; Roelens, Marie; Dalac, Sophie; Maubec, Eve; Caignard, Anne Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. BRAF inhibitor resistance of melanoma cells triggers increased susceptibility to natural killer cell-mediated lysis. Issue 2 (9th September 2020) Authors: Frazao, Alexandra; Rethacker, Louise; Jeudy, Géraldine; Colombo, Marina; Pasmant, Eric; Avril, Marie-Françoise; Toubert, Antoine; Moins-Teisserenc, Helene; Roelens, Marie; Dalac, Sophie; Maubec, Eve; Caignard, Anne Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. BRAF inhibitor resistance of melanoma cells triggers increased susceptibility to natural killer cell-mediated lysis. Issue 2 (9th September 2020) Authors: Frazao, Alexandra; Rethacker, Louise; Jeudy, Géraldine; Colombo, Marina; Pasmant, Eric; Avril, Marie-Françoise; Toubert, Antoine; Moins-Teisserenc, Helene; Roelens, Marie; Dalac, Sophie; Maubec, Eve; Caignard, Anne Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. BRAF inhibitor resistance of melanoma cells triggers increased susceptibility to natural killer cell-mediated lysis. Issue 2 (9th September 2020) Authors: Frazao, Alexandra; Rethacker, Louise; Jeudy, Géraldine; Colombo, Marina; Pasmant, Eric; Avril, Marie-Françoise; Toubert, Antoine; Moins-Teisserenc, Helene; Roelens, Marie; Dalac, Sophie; Maubec, Eve; Caignard, Anne Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. BRAF inhibitor resistance of melanoma cells triggers increased susceptibility to natural killer cell-mediated lysis. Issue 2 (9th September 2020) Authors: Frazao, Alexandra; Rethacker, Louise; Jeudy, Géraldine; Colombo, Marina; Pasmant, Eric; Avril, Marie-Françoise; Toubert, Antoine; Moins-Teisserenc, Helene; Roelens, Marie; Dalac, Sophie; Maubec, Eve; Caignard, Anne Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. BRAF inhibitor resistance of melanoma cells triggers increased susceptibility to natural killer cell-mediated lysis. Issue 2 (9th September 2020) Authors: Frazao, Alexandra; Rethacker, Louise; Jeudy, Géraldine; Colombo, Marina; Pasmant, Eric; Avril, Marie-Françoise; Toubert, Antoine; Moins-Teisserenc, Helene; Roelens, Marie; Dalac, Sophie; Maubec, Eve; Caignard, Anne Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. BRAF inhibitor resistance of melanoma cells triggers increased susceptibility to natural killer cell-mediated lysis. Issue 2 (9th September 2020) Authors: Frazao, Alexandra; Rethacker, Louise; Jeudy, Géraldine; Colombo, Marina; Pasmant, Eric; Avril, Marie-Françoise; Toubert, Antoine; Moins-Teisserenc, Helene; Roelens, Marie; Dalac, Sophie; Maubec, Eve; Caignard, Anne Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. BRAF inhibitor resistance of melanoma cells triggers increased susceptibility to natural killer cell-mediated lysis. Issue 2 (9th September 2020) Authors: Frazao, Alexandra; Rethacker, Louise; Jeudy, Géraldine; Colombo, Marina; Pasmant, Eric; Avril, Marie-Françoise; Toubert, Antoine; Moins-Teisserenc, Helene; Roelens, Marie; Dalac, Sophie; Maubec, Eve; Caignard, Anne Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗